Medicine and Dentistry
Myocardial Infarction
100%
Troponin
100%
Cardiac Troponin
88%
Coronary Computed Tomography Angiography
80%
Coronary Artery Disease
67%
Randomized Controlled Trial
66%
Troponin I
66%
Thorax Pain
33%
Randomized Clinical Trial
33%
Aortic Stenosis
33%
Early Intervention
33%
Cardiac Fibrosis
33%
Clinical Trial
33%
Gabapentin
33%
Pelvis Pain Syndrome
33%
Computed Tomography Angiography
33%
Odds Ratio
26%
Acute Coronary Syndrome
26%
Emergency Department
21%
Hazard Ratio
16%
Conservative Treatment
16%
Patient Assessment
16%
Clinical Trials Unit
16%
Cost-Effectiveness Analysis
12%
Heart Death
11%
Outpatient
11%
Aortic Valve
11%
Placebo
11%
Prospective Cohort Study
10%
Antiplatelet
10%
Sulfanilamide
10%
Statin
10%
Risk Stratification
10%
Intention-to-Treat Analysis
9%
Intervention Trial
8%
Arm
5%
Relative Risk Reduction
5%
Aortic Valve Replacement
5%
New York Heart Association Class
5%
Major Adverse Cardiac Event
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
66%
Troponin
66%
Troponin I
66%
Coronary Artery Disease
61%
Aortic Stenosis
33%
Heart Muscle Fibrosis
33%
Clinical Trial
33%
Randomized Clinical Trial
33%
Acute Coronary Syndrome
20%
Clinical Trials Unit
16%
Sulfanilamide
10%
Statin (Protein)
10%
Antiplatelet
10%
Prospective Cohort Study
10%
Intervention Trial
8%
Nursing and Health Professions
Heart Infarction
33%
Troponin
33%
Troponin I
33%
Computed Tomographic Angiography
33%
Coronary Artery Disease
28%
Acute Coronary Syndrome
9%
Odds Ratio
9%
